Thestra
Thestra is a cancer diagnostics company that translates high-quality academic research into patient-specific companion diagnostics and therapy stratification solutions. Their patented EPLINEx™ technology focuses on identifying aggressive head and neck squamous cell carcinoma (HNSCC), a cancer with nearly one million new cases annually and a 50% mortality rate. By utilizing artificial intelligence for tissue analysis, Thestra aims to provide clinicians with accurate diagnostic tools that facilitate decision-making and improve patient outcomes, ultimately addressing significant unmet medical needs in cancer diagnostics.
Thestra
Thestra is a cancer diagnostics company that translates high-quality academic research into patient-specific companion diagnostics and therapy stratification solutions. Their patented EPLINEx™ technology focuses on identifying aggressive head and neck squamous cell carcinoma (HNSCC), a cancer with nearly one million new cases annually and a 50% mortality rate. By utilizing artificial intelligence for tissue analysis, Thestra aims to provide clinicians with accurate diagnostic tools that facilitate decision-making and improve patient outcomes, ultimately addressing significant unmet medical needs in cancer diagnostics.